Permanent pleural catheter (PPC) for malignant pleural effusion (PE) in advanced non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Martinez Kareaga, M. [1 ]
Urbieta-Macazaga, N. [2 ]
Sanchez-Vieco, C. [3 ]
Tomas-Lopez, L. [3 ]
Intxaurbe-Etxebarria, I. [1 ]
Mareque, B. [1 ]
Torrego, N. [1 ]
Narro, A. [1 ]
Punti, L. [1 ]
Guillen, I. [1 ]
机构：
[1] Hosp Txagorritxu, Med Oncol, Vitoria, Spain
[2] Inst Invest Sanitaria Biodonostia, San Sebastian, Spain
[3] Hosp Txagorritxu, Pneumol, Vitoria, Spain
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
175P
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [1] Implantation of Permanent Pleural Catheter (PPC) for Malignant Pleural Effusion (PE) in Advanced Non Small Cell Lung Cancer (NSCLC)
    Martinez-Kareaga, M.
    Intxaurbe-Etxebarria, I.
    Mareque, B.
    Torrego, N.
    Tomas-Lopez, L.
    Sanchez-Vieco, C.
    Narro, A.
    Punti, L.
    Garcia-Gomez, G.
    Urbieta, N.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S940 - S940
  • [2] Molecular profile of malignant pleural effusion (MPE) in non-small cell lung cancer (NSCLC)
    Rodriguez, Irene Lojo
    Rial, Maribel Botana
    Montaos, Almudena Gonzalez
    Pineiro, Ana Gonzalez
    Hernandez, Cristina Ramos
    Delgado, Mercedes Cuna
    Delgado, Manuel Nunez
    Villar, Alberto Fernandez
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [3] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Hao Zeng
    Yuanyuan Zhang
    Sihan Tan
    Qin Huang
    Xin Pu
    Panwen Tian
    Yalun Li
    BMC Pulmonary Medicine, 24
  • [4] Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion
    Zeng, Hao
    Zhang, Yuanyuan
    Tan, Sihan
    Huang, Qin
    Pu, Xin
    Tian, Panwen
    Li, Yalun
    BMC PULMONARY MEDICINE, 2024, 24 (01)
  • [5] Vandetanib and Indwelling Pleural Catheter for Non-Small-Cell Lung Cancer With Recurrent Malignant Pleural Effusion
    Massarelli, Erminia
    Onn, Amir
    Marom, Edith M.
    Alden, Christine M.
    Liu, Diane D.
    Tran, Hai T.
    Mino, Barbara
    Wistuba, Ignacio I.
    Faiz, Saadia A.
    Bashoura, Lara
    Eapen, George A.
    Morice, Rodolfo C.
    Lee, J. Jack
    Hong, Waun K.
    Herbst, Roy S.
    Jimenez, Carlos A.
    CLINICAL LUNG CANCER, 2014, 15 (05) : 379 - 386
  • [6] THE EFFECT OF CARBOPLATIN PACLITAXEL AND BEVACIZUMAB FOR ADVANCED NON-SMALL CELL LUNG CANCER WITH MALIGNANT PLEURAL EFFUSION
    Kazuyori, Taisuke
    Tamura, Nobumasa
    Sasaki, Ryoko
    Hirano, Yuuta
    Tone, Kazuya
    Shinohara, Wakako
    Kojima, Akira
    Kuwano, Kazuyoshi
    RESPIROLOGY, 2017, 22 : 116 - 116
  • [7] Clinical and Molecular Features of Malignant Pleural Effusion in Non-Small Cell Lung Cancer (NSCLC) of a Caucasian Population
    Lojo-Rodriguez, Irene
    Botana-Rial, Maribel
    Gonzalez-Montaos, Almudena
    Leiro-Fernandez, Virginia
    Gonzalez-Pineiro, Ana
    Ramos-Hernandez, Cristina
    Fernandez-Villar, Alberto
    MEDICINA-LITHUANIA, 2024, 60 (11):
  • [8] Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: Correlations with patient survival and pleural effusion control
    Hsu, I-Lin
    Su, Wu-Chou
    Yan, Jing-Jou
    Chang, Jia-Ming
    Lai, Wu-Wei
    LUNG CANCER, 2009, 65 (03) : 371 - 376
  • [9] The therapeutic efficacy of osimertinib in non-small cell lung cancer with malignant pleural effusion
    Nagamine, Hiroaki
    Sawa, Kenji
    Kaneda, Hiroyasu
    Ogawa, Koichi
    Nakahama, Kenji
    Matsumoto, Yoshiya
    Tani, Yoko
    Mitsuoka, Shigeki
    Kimura, Tatsuo
    Kawaguchi, Tomoya
    ANNALS OF ONCOLOGY, 2022, 33 : S523 - S523
  • [10] Role of molecular testing for malignant pleural effusion in targeted therapy for advanced non-small cell lung cancer
    Lin, Rixu
    Li, Yida
    Lin, Yi
    Tian, Wenyi
    Jiang, Lei
    Li, Jianmin
    DIAGNOSTIC CYTOPATHOLOGY, 2023, 51 (07) : 397 - 405
12345